<code id='14C6DB33D0'></code><style id='14C6DB33D0'></style>

<acronym id='14C6DB33D0'></acronym>

<center id='14C6DB33D0'><center id='14C6DB33D0'><tfoot id='14C6DB33D0'></tfoot></center><abbr id='14C6DB33D0'><dir id='14C6DB33D0'><tfoot id='14C6DB33D0'></tfoot><noframes id='14C6DB33D0'>

<optgroup id='14C6DB33D0'><strike id='14C6DB33D0'><sup id='14C6DB33D0'></sup></strike><code id='14C6DB33D0'></code></optgroup>

<b id='14C6DB33D0'><label id='14C6DB33D0'><select id='14C6DB33D0'><dt id='14C6DB33D0'><span id='14C6DB33D0'></span></dt></select></label></b><u id='14C6DB33D0'></u>

~~<i id='14C6DB33D0'><strike id='14C6DB33D0'><tt id='14C6DB33D0'><pre id='14C6DB33D0'></pre></tt></strike></i>~~

Home» knowledge» explore

explore

explore

author：focus 2025-10-06 12:39:14 Page View：3897

HHS 2020 — PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

advertisement

PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： White House pharmacy plagued with problems, investigation finds
Next article： Drug repurposing or repositioning? The language matters

explore

The high cost of giving birth even with insurance

The high cost of giving birth even with insurance

AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

Sepsis can kill a child within hours. Here's how hospitals are fighting back

Sepsis can kill a child within hours. Here's how hospitals are fighting back

ErosDervishiforSTATFORTWORTH,Texas—Itmightstartoutlookinglikenotmuchmorethananordinarychildhoodfever

Heart attack and stroke risk calculators need revising

Heart attack and stroke risk calculators need revising

AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

BIO to announce reorganization, senior leaders expected to depart

BIOisproceedingwitharestructuringafteritsnewCEOtookover.LaneTurner/TheBostonGlobeWASHINGTON—T

read more